The Effect of Body Mass Index on Melanoma Biology, Immunotherapy Efficacy, and Clinical Outcomes: A Narrative Review

J Jansen, M Garmyn, C Güvenç - International Journal of Molecular …, 2024 - mdpi.com
Recent studies indicate that a higher body mass index (BMI) might correlate with improved
responses to melanoma treatment, especially with immune checkpoint inhibitors (ICIs) …

[HTML][HTML] Sex-specific and sex hormonal-related differences in melanoma microenvironment

S Attorre, F Ugolini, D Lana, MG Giovannini, D Massi - EJC Skin Cancer, 2024 - Elsevier
Growing interest has emerged in the role of sex, as a biological variable that influence the
immunopathogenesis of melanoma. Female patients exhibit significantly better disease …

Antagonism of regulatory ISGs enhances the anti-melanoma efficacy of STING agonists

JN Filderman, JL Taylor, J Wang, Y Zhang… - Frontiers in …, 2024 - frontiersin.org
Background Stimulator of Interferon Genes (STING) is a dsDNA sensor that triggers type I
inflammatory responses. Recent data from our group and others support the therapeutic …

Gender differences in pediatric and adolescent melanoma: A retrospective analysis of 4645 cases

JM Fernandez, JE Koblinski, S Dahak… - Journal of the American …, 2024 - Elsevier
Background There is paucity of data on how gender impacts melanoma prognosis in
pediatric and adolescent patients. Objectives This study explores gender differences in …

Artificial intelligence-assisted metastasis and prognosis model for patients with nodular melanoma

C Xu, X Yu, Z Ding, C Fang, M Gao, W Liu, X Liu, C Yin… - Plos one, 2024 - journals.plos.org
Objective The objective of this study was to identify the risk factors that influence metastasis
and prognosis in patients with nodular melanoma (NM), as well as to develop and validate a …

HLA-E and Its Soluble Form as Indicators of a Sex-Specific Immune Response in Patients with Oral Squamous Cell Carcinoma

A Radermacher, M Fehrenz, T Bellin, C Claßen… - International Journal of …, 2023 - mdpi.com
The human leukocyte antigene E (HLA-E) is associated with tumorigenesis in various
cancers. Immunoncology along with sex-specific aspects in cancer therapy are now in …

Differential time series analysis shows deceleration in melanoma mortality prior to the widespread use of highly effective therapies

DI Latoni, YR Semenov, H Tsao - Journal of the American Academy of …, 2024 - Elsevier
Background Although the recent drop in melanoma mortality has been attributed to the
introduction of newer therapies, the impact of ongoing public efforts remains unknown …

The role of STING agonist-induced interferon stimulated genes in the anti-melanoma immune response

JN Filderman - 2024 - search.proquest.com
Successful infiltration of pro-inflammatory immune cells into the tumor can promote an anti-
tumor microenvironment that leads to tumor growth control and regression. However, the …

Geschlechterspezifische Bedeutung von HLA-E und seiner löslichen Form für Patientinnen und Patienten mit oralem Plattenepithelkarzinom

A Radermacher - 2024 - publikationen.sulb.uni-saarland.de
Orale Plattenepithelkarzinome (OSCC) gehören zu den häufigsten Tumorentitäten weltweit.
Trotz Bemühungen in der Forschung und der Therapie ist die Prognose weiterhin schlecht …

[PDF][PDF] Discovery and Validation of Sex-Specific Survival Biomarkers in Early-Stage Cutaneous Melanoma

E Chrysanthou - 2024 - iris.unito.it
Background: There are multiple sex disparities across numerous cancers affecting
incidence, survival, and treatment response. In cutaneous melanoma (CM), men have a …